Isabel has returned to the group following a three month internship at Alkermes Biopharmaceutical. During the internship Isabel worked as part of the R&D Formulations department, developing formulations for new oral dose drug substances, which allowed her to get experience in early stage formulation development through to scale-up, as well as investigating the potential for PAT (Process Analytical Technology), in the form of various spectroscopic techniques, with a view to inline process monitoring. This opportunity was made possible due to a collaboration with Tarek Zeidan (Alkermes, Waltham) on Isabel’s PhD project over the last three years. This experience will greatly benefit Isabel as well as the wider Gunnlaugsson group.
The TG group had the pleasure of hosting a delegation from the biopharmaceutical company Alkermes earlier today. A fast-paced morning of talks were held in TBSI, where postgraduate students and postdoctoral researchers alike presented their work to the company. This was followed by a lunch and poster session at which much fruitful discussion took place. The group included Tarek Zeidan, Principal Scientist at the company, who works in collaboration with second year group member Isabel Hegarty.
The TG Group had a very productive meeting with a delegation of scientists from biopharmaceutical company Alkermes. A lot of fascinating discussion and knowledge exchange went on over the course of the afternoon and there was even time to visit the Book of Kells in Trinity’s Old Library. Students and postdoctoral researchers presented their work and fruitful discussion about the limitations and applications of various projects followed.